Laminins play a fundamental role in basement membrane architecture and function in human skin. The C-terminal laminin G domain-like (LG) modules of laminin α chains are modified by proteolysis to generate LG1-3 and secreted LG4-5 tandem modules. In this study, we provide evidence that skin-derived cells process and secrete biologically active peptides from the LG4-5 module of the laminin α3, α4 and α5 chain in vitro and in vivo. We show enhanced expression and processing of the LG4-5 module of laminin α3 in keratinocytes after infection and in chronic wounds in which the level of expression and further processing of the LG4-5 module correlated with the speed of wound healing. Furthermore, bacterial or host-derived proteases promote processing of laminin α3 LG4-5. On a functional level, we show that LG4-5-derived peptides play a role in wound healing. Moreover, we demonstrate that LG4-derived peptides from the α3, α4 and α5 chains have broad antimicrobial activity and possess strong chemotactic activity to mononuclear cells. Thus, the data strongly suggest a novel multifunctional role for laminin LG4-5-derived peptides in human skin and its involvement in physiological processes and pathological conditions such as inflammation, chronic wounds and skin infection.

Journal Section:
Editor's choice
Keywords:
Extracellular matrix, Laminin, Antimicrobial peptides, Wound healing, Chemotaxis, Host defense
1.
Burgeson RE, Christiano AM: The dermal-epidermal junction. Curr Opin Cell Biol 1997;9:651-658.
[PubMed]
https://doi.org/10.1016/S0955-0674(97)80118-4
2.
Durbeej M: Laminins. Cell Tissue Res 2010;339:259-268.
[PubMed]
https://doi.org/10.1007/s00441-009-0838-2
3.
Marinkovich MP: Laminin 332 in squamous-cell carcinoma. Nat Rev Cancer 2007;7:370-380.
[PubMed]
https://doi.org/10.1038/nrc2089
4.
Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R, Edgar D, Ekblom P, Engel J, Engvall E, Hohenester E, Jones JCR, Kleinman HK, Marinkovich MP, Martin GR, Mayer U, Meneguzzi G, Miner JH, Miyazaki K, Patarroyo M, Paulsson M, Quaranta V, Sanes JR, Sasaki T, Sekiguchi K, Sorokin LM, Talts JF, Tryggvason K, Uitto J, Virtanen I, von der Mark K, Wewer UM, Yamada Y, Yurchenco PD: A simplified laminin nomenclature. Matrix Biol 2005;24:326-332.
[PubMed]
https://doi.org/10.1016/j.matbio.2005.05.006
5.
Miner JH, Yurchenco PD: Laminin functions in tissue morphogenesis. Annu Rev Cell Dev Biol 2004;20:255-284.
[PubMed]
https://doi.org/10.1146/annurev.cellbio.20.010403.094555
6.
Talts JF, Sasaki T, Miosge N, Gohring W, Mann K, Mayne R, Timpl R: Structural and functional analysis of the recombinant G domain of the laminin alpha 4 chain and its proteolytic processing in tissues. J Biol Chem 2000;275:35192-35199.
[PubMed]
https://doi.org/10.1074/jbc.M003261200
7.
Timpl R, Tisi D, Talts JF, Andac Z, Sasaki T, Hohenester E: Structure and function of laminin LG modules. Matrix Biol 2000;19:309-317.
[PubMed]
https://doi.org/10.1016/S0945-053X(00)00072-X
8.
Tisi D, Talts JF, Timpl R, Hohenester E: Structure of the C-terminal laminin G-like domain pair of the laminin alpha 2 chain harbouring binding sites for alpha-dystroglycan and heparin. EMBO J 2000;19:1432-1440.
[PubMed]
https://doi.org/10.1093/emboj/19.7.1432
9.
Rousselle P, Beck K: Laminin 332 processing impacts cellular behavior. Cell Adh Migr 2013;7:122-134.
[PubMed]
https://doi.org/10.4161/cam.23132
10.
Rousselle P, Carulli S, Chajra H, Dayan G, Pin D, Herbage B: The syndecan binding sequence KKLRIKSKEK in laminin alpha3 LG4 domain promotes epidermal repair. Eur J Dermatol 2013, Epub ahead of print.
[PubMed]
11.
Matsuura H, Momota Y, Murata K, Matsushima H, Suzuki N, Nomizu M, Shinkai H, Utani A: Localization of the laminin alpha4 chain in the skin and identification of a heparin-dependent cell adhesion site within the laminin alpha4 chain C-terminal LG4 module. J Invest Dermatol 2004;122:614-620.
[PubMed]
https://doi.org/10.1111/j.0022-202X.2004.22325.x
12.
Sugawara K, Tsuruta D, Ishii M, Jones JC, Kobayashi H: Laminin-332 and -511 in skin. Exp Dermatol 2008;17:473-480.
[PubMed]
https://doi.org/10.1111/j.1600-0625.2008.00721.x
13.
Senyurek I, Klein G, Kalbacher H, Deeg M, Schittek B: Peptides derived from the human laminin alpha 4 and alpha 5 chains exhibit antimicrobial activity. Peptides 2010;31:1468-1472.
[PubMed]
https://doi.org/10.1016/j.peptides.2010.04.016
14.
Adair-Kirk TL, Senior RM: Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol 2008;40:1101-1110.
[PubMed]
https://doi.org/10.1016/j.biocel.2007.12.005
15.
Tran KT, Lamb P, Deng JS: Matrikines and matricryptins: implications for cutaneous cancers and skin repair. J Dermatol Sci 2005;40:11-20.
[PubMed]
https://doi.org/10.1016/j.jdermsci.2005.05.001
16.
Tolar J, Xia L, Lees CJ, Riddle M, McElroy A, Keene DR, Lund TC, Osborn MJ, Marinkovich MP, Blazar BR, Wagner JE: Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa. J Invest Dermatol 2013;133:562-565.
[PubMed]
https://doi.org/10.1038/jid.2012.278
17.
Wanke I, Steffen H, Christ C, Krismer B, Gotz F, Peschel A, Schaller M, Schittek B: Skin commensals amplify the innate immune response to pathogens by activation of distinct signaling pathways. J Invest Dermatol 2011;131:382-390.
[PubMed]
https://doi.org/10.1038/jid.2010.328
18.
Okamoto O, Bachy S, Odenthal U, Bernaud J, Rigal D, Lortat-Jacob H, Smyth N, Rousselle P: Normal human keratinocytes bind to the alpha3LG4/5 domain of unprocessed laminin-5 through the receptor syndecan-1. J Biol Chem 2003;278:44168-44177.
[PubMed]
https://doi.org/10.1074/jbc.M300726200
19.
Obernesser HJ, Doring G, Botzenhart K: Extracellular toxins of Pseudomonas aeruginosa. I. Purification and characterization of two exoproteases. Zentralbl Bakteriol A 1981;249:76-88.
[PubMed]
20.
Fleischmajer R, Kuroda K, Utani A, Douglas ME, Perlish JS, Arikawa-Hirasawa E, Sekiguchi K, Sanzen N, Timpl R, Yamada Y: Differential expression of laminin alpha chains during proliferative and differentiation stages in a model for skin morphogenesis. Matrix Biol 2000;19:637-647.
[PubMed]
https://doi.org/10.1016/S0945-053X(00)00092-5
21.
Yamasaki K, Schauber J, Coda A, Lin H, Dorschner RA, Schechter NM, Bonnart C, Descargues P, Hovnanian A, Gallo RL: Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J 2006;20:2068-2080.
[PubMed]
https://doi.org/10.1096/fj.06-6075com
22.
Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jornvall H, Wigzell H, Gudmundsson GH: The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000;96:3086-3093.
[PubMed]
23.
Andersson E; Rydengard V, Sonesson A, Morgelin M, Bjorck L, Schmidtchen A: Antimicrobial activities of heparin-binding peptides. Eur J Biochem 2004;271:1219-1226.
[PubMed]
https://doi.org/10.1111/j.1432-1033.2004.04035.x
24.
Malmsten M, Davoudi M, Schmidtchen A: Bacterial killing by heparin-binding peptides from PRELP and thrombospondin. Matrix Biol 2006;25:294-300.
[PubMed]
https://doi.org/10.1016/j.matbio.2006.04.003
25.
Fjell CD, Hiss JA, Hancock RE, Schneider G: Designing antimicrobial peptides: form follows function. Nat Rev Drug Discov 2012;11:37-51.
[PubMed]
https://doi.org/10.1038/nrd3591
26.
Menzies BE, Kenoyer A: Staphylococcus aureus infection of epidermal keratinocytes promotes expression of innate antimicrobial peptides. Infect Immun 2005;73:5241-5244.
[PubMed]
https://doi.org/10.1128/IAI.73.8.5241-5244.2005
27.
Fink DL, Green BA, St Geme JW III: The Haemophilus influenzae Hap autotransporter binds to fibronectin, laminin, and collagen IV. Infect Immun 2002;70:4902-4907.
[PubMed]
https://doi.org/10.1128/IAI.70.9.4902-4907.2002
28.
Rambukkana A, Salzer JL, Yurchenco PD, Tuomanen EI: Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-alpha2 chain. Cell 1997;88:811-821.
[PubMed]
https://doi.org/10.1016/S0092-8674(00)81927-3
29.
Singh B, Fleury C, Jalalvand F, Riesbeck K: Human pathogens utilize host extracellular matrix proteins laminin and collagen for adhesion and invasion of the host. FEMS Microbiol Rev 2012;36:1122-1180.
[PubMed]
https://doi.org/10.1111/j.1574-6976.2012.00340.x
30.
Tronchin G, Bouchara JP, Larcher G, Lissitzky JC, Chabasse D: Interaction between Aspergillus fumigatus and basement membrane laminin: binding and substrate degradation. Biol Cell 1993;77:201-208.
[PubMed]
https://doi.org/10.1016/S0248-4900(05)80189-3
31.
Timpl R: Macromolecular organization of basement membranes. Curr Opin Cell Biol 1996;8:618-624.
[PubMed]
https://doi.org/10.1016/S0955-0674(96)80102-5
32.
O'Toole EA: Extracellular matrix and keratinocyte migration. Clin Exp Dermatol 2001;26:525-530.
[PubMed]
https://doi.org/10.1046/j.1365-2230.2001.00891.x
33.
Momota Y, Suzuki N, Kasuya Y, Kobayashi T, Mizoguchi M, Yokoyama F, Nomizu M, Shinkai H, Iwasaki T, Utani A: Laminin alpha3 LG4 module induces keratinocyte migration: involvement of matrix metalloproteinase-9. J Recept Signal Transduct Res 2005;25:1-17.
[PubMed]
https://doi.org/10.1081/RRS-200047870
34.
Carulli S, Beck K, Dayan G, Boulesteix S, Lortat-Jacob H, Rousselle P: Cell surface proteoglycans syndecan-1 and -4 bind overlapping but distinct sites in laminin alpha3 LG45 protein domain. J Biol Chem 2012;287:12204-12216.
[PubMed]
https://doi.org/10.1074/jbc.M111.300061
35.
Hermann M, Jaconi ME, Dahlgren C, Waldvogel FA, Stendahl O, Lew DP: Neutrophil bactericidal activity against Staphylococcus aureus adherent on biological surfaces. Surface-bound extracellular matrix proteins activate intracellular killing by oxygen-dependent and -independent mechanisms. J Clin Invest 1990;86:942-951.
[PubMed]
https://doi.org/10.1172/JCI114796
36.
Newman SL, Tucci MA: Regulation of human monocyte/macrophage function by extracellular matrix. Adherence of monocytes to collagen matrices enhances phagocytosis of opsonized bacteria by activation of complement receptors and enhancement of Fc receptor function. J Clin Invest 1990;86:703-714.
[PubMed]
https://doi.org/10.1172/JCI114766
37.
Mansfield PJ, Suchard SJ: Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol 1994;153:4219-4229.
[PubMed]
38.
Hunninghake GW, Davidson JM, Rennard S, Szapiel S, Gadek JE, Crystal RG: Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science 1981;212:925-927.
[PubMed]
https://doi.org/10.1126/science.7233186
39.
Lin L, BetsuyakuT, Heimbach L, Li N, Rubenstein D, Shapiro SD, An L, Giudice GJ, Diaz LA, Senior RM, Liu Z: Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid. Matrix Biol 2012;31:38-44.
[PubMed]
https://doi.org/10.1016/j.matbio.2011.09.003
40.
Mydel P, Shipley JM, Adair-Kirk TL, Kelley DG, Broekelmann TJ, Mecham RP, Senior RM: Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J Biol Chem 2008;283:9513-9522.
[PubMed]
https://doi.org/10.1074/jbc.M706239200
41.
Kenne E, Soehnlein O, Genove G, Rotzius P, Eriksson EE, Lindbom L: Immune cell recruitment to inflammatory loci is impaired in mice deficient in basement membrane protein laminin alpha4. J Leukoc Biol 2010;88:523-528.
[PubMed]
https://doi.org/10.1189/jlb.0110043
42.
Adair-Kirk TL, Atkinson JJ, Broekelmann TJ, Doi M, Tryggvason K, Miner JH, Mecham RP, Senior RM: A site on laminin alpha 5, AQARSAASKVKVSMKF, induces inflammatory cell production of matrix metalloproteinase-9 and chemotaxis. J Immunol 2003;171:398-406.
[PubMed]
https://doi.org/10.4049/jimmunol.171.1.398
43.
Spenlé C, Hussenet T, Lacroute J, Lefebvre O, Kedinger M, Orend G, Simon-Assmann P: Dysregulation of laminins in intestinal inflammation. Pathol Biol (Paris) 2012;60:41-47.
[PubMed]
https://doi.org/10.1016/j.patbio.2011.10.005
44.
Abdillahi SM, Balvanovic S, Baumgarten M, Morgelin M: Collagen VI encodes antimicrobial activity: novel innate host defense properties of the extracellular matrix. J Innate Immun 2012;4:371-376.
[PubMed]
https://doi.org/10.1159/000335239
© 2014 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2014
You do not currently have access to this content.